Navigation Links
BGI announces collaboration with Johns Hopkins University on synthetic yeast project
Date:11/14/2011

November 14th, 2011, Shenzhen, China BGI the world's largest genomic organization and Johns Hopkins University (JHU), today signed a collaborative research agreement for the synthetic yeast project (SC2.0 PROJECT), an ambitious synthetic biology project which seeks to re-design and synthesize the yeast genome. This project was initiated by JHU and serves as part of JHU's synthetic biology program.

In addition to the research collaboration of SC2.0 PROJECT, BGI's researchers will have the opportunity to access the synthetic biology expertise of JHU. They can attend for internship the undergraduate course, "Build-A-Genome," associated with the project at JHU. During the course, they can perform synthesis of segments of the synthetic yeast genome by themselves.

The signing ceremony was held during the "6th International Conference on Genomics" hosted by BGI in Shenzhen from Nov. 12 to 15, 2011. The ceremony was attended by Dr. Huanming Yang, Chairman of BGI; three principal investigators of the project, Dr. Jef Boeke, Director of the High Throughput Biology Center, Johns Hopkins University School of Medicine, Joel Bader, Associate Professor of the High Throughput Biology Center, Johns Hopkins University School of Medicine, and Dr. Yizhi Cai, Autodesk Distinguished Scholar of the High Throughput Biology Center, Johns Hopkins University School of Medicine; and Yue Shen, Head of Synthetic Biology Unit at BGI. Key representatives of BGI Americas presented including Ruth Kaucher, Vice President of Scientific Liaison, Americas and Dr. Joyce Peng, Marketing Director.

"Synthetic biology is a new emerging research field, which provides a unique opportunity for researchers to study many profound life science questions. When biological researchers are transitioning from the DNA sequence of an organism to a synthetic genome, researchers will face more challenges and opportunities with synthetic biology," stated Prof. Yang. "With JHU's valuable skill, experience and ability in the research of synthetic biology, we believe we can achieve significant breakthroughs in the future study of synthetic biology."

Synthetic biology aims to design synthetic biological systems utilizing genetic engineered micro-organisms for the production of biofuels and drugs. It can help scientists to understand the living system of natural organisms, such as biological mechanisms, responses and adaptation to various environmental conditions, evolution, among others. Synthetic biology is expected to provide ground breaking applications with engineered biology systems designed and built to help in the production of chemicals, energy and food to maintain and enhance human health and the environment.

With a well-understood genome and the wide applications of yeast in bioremediation, food processing, medicine, etc, yeast has been an excellent model organism used in the studies of synthetic biology. In the SC2.0 PROJECT, the yeast S. cerevisiae is used as the basis for a newly engineered life form that resulted from specific alternations incorporated into the synthetic chromosomes. The "synthetic yeast" approach can be used to answer a wide variety of profound questions about fundamental properties of chromosomes, genome organization, gene content, the function of RNA splicing, and questions relating to genome structure and evolution.

The rapid development of high-throughput sequencing technology has led to a boom in genomic information of different organisms, which also facilitates the rapid detection and identification of synthetic systems and organisms. Meanwhile, it could help synthetic biologists to verify an engineered biological system as proposed, given that the DNA sequences of the single gene or entire genome are designed by computer and then built by chemical synthesis.

"As the first artificial eukaryotic cell genome project, SC2.0 PROJECT will play a significant role in the history of the development of biotechnology. With the rapid development of next generation sequencing technology, I believe we can seek much better solutions to face the challenges in Synthetic Biology." said Yue Shen. "We really appreciate this opportunity to collaborate with JHU. With this project, I believe BGI will be able to explore more opportunities for valuable research in human disease and biomedical areas" she added.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. Elsevier announces new 2012 Frontlist eBooks collection on SciVerse ScienceDirect
2. Wayne State announces license agreement for breakthrough approaches to vision restoration
3. SomaLogic announces agreement with leading global pharma company to accelerate R&D
4. Trudeau Institute announces its latest discovery in the fight against tuberculosis
5. Biophysical Society announces 2012 Society Fellows
6. White House announces that 2 UCSB faculty members will receive US presidential science awards
7. FASEB announces new client: The Histochemical Society
8. MedNet Solutions Announces the Latest Release of iMedNet EDC
9. FASEB MARC program announces the travel award recipients for the 2011 Leadership Development and Grant Writing Seminar for graduate students, postdoctoral fellows and new assistant professors
10. Trudeau Institute announces new discovery in battle against infections
11. Wiley-Blackwell announces continued growth in impact factor journals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)...   Acuant , a leading provider of data ... to new and core technologies building upon the acquisition ... and desktop Acuant FRM TM facial recognition and ... time manual review of identity documents by accredited professionals. ... and most accurate capture software to streamline workflows by ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... , March 28, 2017 /PRNewswire/ -RepliCel Life Sciences Inc. ... pleased to report compelling safety and clinical data from its ... type 1 collagen-expressing, hair follicle-derived fibroblasts (RCT-01) as a treatment ... ... establishing a complete safety profile at 6 months and showed ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... as Chief Executive Officer with Avomeen Analytical Services. Harvill is a distinguished life ... operations. , Avomeen is a leader in a wide range of services ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the fight against cancer, autoimmune disease and more through a single-cell precision engineering ... and proteomics analysis platform developed in the laboratory of Dr. James Heath ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from non-small ... samples with limited tumor content in a large background of normal or wild ... the need for reliable detection of low abundance somatic mutations, particularly in small ...
Breaking Biology Technology: